Excess risks of long COVID symptoms compared with identical symptoms in the general population: A systematic review and meta-analysis of studies with control groups. — CFSMEATLAS
Excess risks of long COVID symptoms compared with identical symptoms in the general population: A systematic review and meta-analysis of studies with control groups.
Xu, Zijun, Wang, Wenyue, Zhang, Dexing et al. · Journal of global health · 2024 · DOI
Quick Summary
This study examined whether people who had COVID-19 experience certain long-lasting symptoms more often than people who never had COVID-19. Researchers combined results from 51 studies involving millions of people and found that COVID-19 survivors had about twice the risk of developing long COVID symptoms. The most striking findings were for loss of smell and taste, followed by post-exertional malaise (feeling worse after activity), shortness of breath, brain fog, and fatigue.
Why It Matters
For ME/CFS patients and researchers, this study provides robust quantitative evidence that post-exertional malaise and cognitive dysfunction are genuine excess symptoms following COVID-19, not merely background population prevalence. This meta-analysis strengthens the case for recognizing long COVID and ME/CFS overlap syndromes as legitimate medical conditions requiring specific interventions, not psychiatric attribution.
Observed Findings
Participants with COVID-19 had 2.03-fold higher risk of having at least one long COVID symptom compared to non-COVID controls
Osmia loss showed the highest excess risk (OR=8.47), followed by dysgeusia (OR=5.88) and post-exertional malaise (OR=3.19)
Fatigue affected 1.97 times more COVID-19 survivors than controls; cognitive decline 1.99 times more
Follow-up time ≥3 months showed persistent excess risk without consistent decline over longer periods
Adults had significantly higher risks of cognitive decline, hair loss, and joint pain compared to children
Inferred Conclusions
COVID-19 infection significantly increases risk across multiple symptom domains, with particularly strong associations for chemosensory loss and post-exertional malaise
Long COVID symptoms persist beyond 3 months post-infection at elevated risk levels independent of gender
The broad spectrum and multi-system nature of elevated symptom risks supports the need for targeted clinical services and interventions for long COVID
Symptom patterns differ between adults and children, suggesting potentially different post-viral pathophysiology or recovery trajectories by age
Remaining Questions
What are the biological mechanisms underlying the elevated risk of post-exertional malaise, brain fog, and cognitive decline in COVID-19 survivors?
What This Study Does Not Prove
This meta-analysis demonstrates association, not causation, and does not establish mechanism. It does not determine whether long COVID and ME/CFS are identical conditions, whether symptoms represent persistent viral infection or post-viral dysfunction, or whether documented symptoms constitute the same phenotype across all studies. The study also cannot assess individual-level outcomes or predict which COVID-19 survivors will develop long-term illness.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →